Indeed, a shorter protein half life of SCD5 was evidenced in advanced melanoma compared to primary ones (Figure 1A), supporting the presence of biological processes aimed at preventing accumulation of SCD5 in metastatic cells. Here, SCD5 is linked to melanoma.